Events & Presentations – Rhythm Pharmaceuticals, Inc.

Corporate Presentation

Rhythm Corporate Presentation – September 2026

View report

Upcoming Events

November 3, 2026 8:00 AM EST

Rhythm Pharmaceuticals Q3 2026 Earnings Conference Call

Click here for webcast

Add to Outlook

Add to Google Calendar

November 9, 2026 9:00 AM EST

Guggenheim 3rd Annual Healthcare Innovation Conference

Click here for webcast

Add to Outlook

Add to Google Calendar

November 11, 2026 11:20 AM EST

Stifel 2026 Healthcare Conference

Click here for webcast

Add to Outlook

Add to Google Calendar

Past Events

September 15, 2026 1:50 PM EDT

Morgan Stanley 24th Annual Global Healthcare Conference

Click here for webcast

September 9, 2026 3:00 PM EDT

Wells Fargo 21st Annual Healthcare Conference

Click here for webcast

August 12, 2026 9:00 AM EDT

Canaccord Genuity 46th Annual Growth Conference

Click here for webcast

August 4, 2026 8:00 AM EDT

Rhythm Pharmaceuticals Q2 2026 Earnings Conference Call

Click here for webcast

Rhythm Pharmaceuticals Q2 2026 Earnings Conference Call Presentation 1.3 MB

June 13, 2026 9:00 AM EDT

Results from Phase 2 Trial Evaluating Setmelanotide in PWS at Six Months

Listen to webcast

Positive Interim Six-month Results from Phase 2 Trial Evaluating Setmelanotide in Patients with Prader-Willi Syndrome 1.9 MB

June 8, 2026 1:20 PM EDT

Goldman Sachs 47th Annual Global Healthcare Conference

Listen to webcast

June 4, 2026 12:50 PM EDT

Jefferies Global Healthcare Conference

Listen to webcast

May 13, 2026 6:00 PM EDT

Bank of America Global Healthcare Conference

Listen to webcast

May 5, 2026 8:00 AM EDT

Rhythm Pharmaceuticals Q1 2026 Earnings Conference Call

Listen to webcast

Rhythm Pharmaceuticals Q1 2026 Earnings Conference Call Presentation 2.2 MB

April 16, 2026 11:00 AM EDT

25th Annual Needham Virtual Healthcare Conference

Listen to webcast

March 19, 2026 7:00 PM EDT

IMCIVREE Approved by FDA for Acquired Hypothalamic Obesity

Listen to webcast

IMCIVREE Approved by FDA for Acquired Hypothalamic Obesity Presentation 1.1 MB

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

March 16, 2026 4:30 PM EDT

Phase 3 EMANATE Trial Topline Results

Listen to webcast

Rhythm Pharmaceuticals Conference Presentation 1.4 MB

March 2, 2026 11:10 AM EST

TD Cowen 46th Annual Health Care Conference

Listen to webcast

February 26, 2026 8:00 AM EST

Rhythm Pharmaceuticals 4Q and FY 2025 Earnings Conference Call

Listen to webcast

Rhythm Pharmaceuticals Q4 2025 Earnings Conference Call Presentation 2.5 MB

February 11, 2026 11:00 AM EST

Guggenheim Emerging Outlook: Biotech Summit 2026

Listen to webcast

Presentations

2025 Sustainability Report

View report

Rhythm Corporate Presentation – September 2026

View report

Rhythm Corporate Presentation – June 2026

View report

Rhythm Corporate Presentation – April 2026

View report

Rhythm Pharmaceuticals Q3 2025 Earnings Conference Call Presentation

View report

2024 Sustainability Report

View report

Rhythm Pharmaceuticals 2024 Annual Report

View report

Rhythm Pharmaceuticals Q2 2025 Earnings Conference Call Presentation

View report

Rhythm Pharmaceutical Conference Call - Rhythm Biva Ph2 Topline Presentation

View report

Rhythm Pharmaceuticals Q1 2025 Earnings Conference Call Presentation

View report

Rhythm Pharmaceutical Conference Call - Rhythm HO Ph3 Topline Presentation

View report

Rhythm Pharmaceuticals Q4 2024 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals Q3 2024 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals Q2 2024 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals Q1 2024 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals Q4 2023 Earnings Conference Call Presentation

View report

Rhythm Update on MC4R Pathway Programs – Dec. 23, 2023

View report

Rhythm Pharmaceuticals Q3 2023 Earnings Conference Call Presentation

View report

Rhythm Pharmaceutical Conference Call - ObesityWeek® 2023 Data Presentations

View report

Rhythm Pharmaceuticals Q2 2023 Earnings Conference Call Presentation

View report

Weight Reduction After 6 Months of Setmelanotide Treatment in Patients With Hypothalamic Obesity, ENDO 2023

View report

Rhythm Pharmaceuticals Q1 2023 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals Q4 2022 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals Q3 2022 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals – Hypothalamic Obesity

View report

Rhythm Pharmaceuticals Q2 2022 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals Conference Call – Hypothalamic Obesity Presentation

View report

Rhythm Pharmaceuticals Conference Call

View report

Rhythm Pharmaceuticals Q1 2022 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals Q4 2021 Earnings Conference Call Presentation

View report

Rhythm Pharmaceuticals Q3 2021 Earnings Conference Call Presentation

View report

Rhythm Event to Provide Update on Phase 2 Basket Study and Genetic Sequencing Efforts